Clinical Trials Directory

Trials / Completed

CompletedNCT00000324

Tryptophan and Behavior Therapy for Cocaine Abuse - 1

Tryptophan and Behavior Therapy for Cocaine Abuse

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
200 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the efficacy of tryptophan vs. placebo, and voucher payments vs. a control condition, in the treatment of cocaine dependence.

Detailed description

This clinical trial uses a 2 by 2 design to compare tryptophan to placebo, and voucher incentives vs. a control condition, in the outpatient treatment of cocaine dependence- using a relapse prevention model of treatment intervention.

Conditions

Interventions

TypeNameDescription
DRUGTryptophan

Timeline

Start date
1997-03-01
Completion
2001-04-01
First posted
1999-09-21
Last updated
2017-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000324. Inclusion in this directory is not an endorsement.